Adaptive Neurovascular Flow Control Systems

A next-generation vessel flow control technology that integrates AI, genomics, and decentralized networks to provide personalized, real-time treatment of afflicted vessels and associated tissues.

The original patent's vessel flow control devices and methods, while effective, have limitations in terms of adaptability, precision, and data-driven decision making. The new inventive concept addresses these limitations by envisioning a future where vessel flow control is dynamically optimized using advanced analytics, genomics, and AI-driven occlusion strategies.

The inventive concept comprises a range of interconnected components, including neural network-based predictive analytics modules, dynamically configurable occlusion devices, genomic analysis tools, brain-computer interfaces, and decentralized blockchain-based networks. These components work in concert to provide real-time, personalized treatment of afflicted vessels and associated tissues. The system learns from patient physiological responses and adapts its occlusion strategy over time, enabling more effective and efficient treatment outcomes.

The new claims introduce a paradigm shift in vessel flow control by incorporating AI, genomics, and decentralized networks. The inventive concept's use of predictive analytics, genomic profiling, and real-time occlusion adjustment represents a significant departure from the original patent's more static and manual approach.

Alternative embodiments of the inventive concept could include the use of edge computing for faster data processing, integration with wearables and IoT devices for more comprehensive patient monitoring, or the development of specialized occlusion devices for specific vascular conditions.

The inventive concept has significant commercial potential in the medical device and healthcare industries, particularly in the areas of cardiovascular disease treatment, neurovascular therapy, and personalized medicine. The market for such advanced vessel flow control systems is expected to grow significantly in the coming years, driven by increasing demand for more effective and efficient treatment options.